|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01612 VINCENT MED
Nominal 
0.930 -0.010 (-1.064%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | -- | -- | 800,963 | 717,973 | 629,242 | 777,720 |
| Cost of Sales | -- | -- | (540,971) | (477,586) | (463,889) | (518,616) |
| Gross Profit | -- | -- | 259,992 | 240,387 | 165,353 | 259,104 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | (328) | 2,817 | (1,664) | (5,879) | |
| Profit / (Loss) before Taxation | -- | -- | 77,979 | 66,915 | (15,516) | 66,180 | |
| Taxation | -- | -- | (7,083) | (8,707) | (2,874) | (6,110) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | (1,729) | (933) | 992 | 625 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 104,378 | 50.907% | 69,167 | 57,275 | (17,398) | 60,695 | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | -- | -- | 159 | 985 | 2,342 | 2,046 |
| Depreciation & Amortisation | -- | -- | 36,568 | 38,331 | 40,952 | 40,063 |
| Directors' Emoluments | -- | -- | 7,058 | 6,856 | 7,245 | 6,912 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 16.180 | 50.512% | 10.750 | 8.870 | -2.660 | 9.280 |
| DPS (cts) | 5.000 | -- | 3.300 | 2.750 | 2.500 | 4.500 |
| Dividend Payout Ratio (%) | 30.902% | -- | 30.698% | 31.003% | -- | 48.491% |
| Cash flow per share ($) | -- | -- | 0.114 | 0.194 | 0.116 | 0.182 |
| NBV per share ($) | -- | -- | 0.886 | 0.829 | 0.762 | 0.914 |
| Remarks: | Real time quote last updated: 26/03/2026 12:23 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 104,378 |
| %Change | 50.907% |
| EPS / (LPS) | HKD 0.162 |
| NBV Per Share ($) | HKD -- |